These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 426105)

  • 1. Plasma growth hormone: effect of anxiety during flooding in vivo.
    Curtis GC; Nesse R; Buxton M; Lippman D
    Am J Psychiatry; 1979 Apr; 136(4A):410-4. PubMed ID: 426105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Flooding in vivo" during the circadian phase of minimal cortisol secretion: anxiety and therapeutic success without adrenal cortical activation.
    Curtis G; Buxton M; Lippman D; Nesse R; Wright J
    Biol Psychiatry; 1976 Feb; 11(1):101-7. PubMed ID: 1260072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety induced by flooding therapy for phobias does not elicit prolactin secretory response.
    Nesse RM; Curtis GC; Brown GM; Rubin RT
    Psychosom Med; 1980 Jan; 42(1):25-31. PubMed ID: 7394142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cortisol and growth hormone responses to intravenous characterization.
    Rose RM; Hurst MW
    J Human Stress; 1975 Mar; 1(1):22-36. PubMed ID: 1235112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged exposure (flooding) in phobic and obsessive compulsive patients: 21 cases (author's transl)].
    Cottraux J; Mollard E
    Nouv Presse Med; 1978 Mar; 7(12):1003-6. PubMed ID: 662607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotherapy in the overall management strategy for social anxiety disorder.
    Shear MK; Beidel DC
    J Clin Psychiatry; 1998; 59 Suppl 17():39-46. PubMed ID: 9811429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral techniques in the treatment of a writing phobia.
    Menks F
    Am J Occup Ther; 1979 Feb; 33(2):102-7. PubMed ID: 34987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis.
    Parsons TD; Rizzo AA
    J Behav Ther Exp Psychiatry; 2008 Sep; 39(3):250-61. PubMed ID: 17720136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention to phobic stimuli during exposure: the effect of distraction on anxiety reduction, self-efficacy and perceived control.
    Johnstone KA; Page AC
    Behav Res Ther; 2004 Mar; 42(3):249-75. PubMed ID: 14975769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of laboratory-provoked anxiety on plasma homovanillic acid concentration in normal subjects.
    Zemishlany Z; Davidson M
    Biol Psychiatry; 1996 Aug; 40(4):247-52. PubMed ID: 8871770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia?
    Borgeat F; Stankovic M; Khazaal Y; Rouget BW; Baumann MC; Riquier F; O'Connor K; Jermann F; Zullino D; Bondolfi G
    J Nerv Ment Dis; 2009 Jul; 197(7):507-13. PubMed ID: 19597358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flooding in vivo as research tool and treatment method for phobias: a preliminary report.
    Curtis G; Nesse R; Buxton M; Wright J; Lippman D
    Compr Psychiatry; 1976; 17(1):153-60. PubMed ID: 1248229
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive relaxation and implosion therapy for dental phobias.
    Hoorwitz LG
    Clin Prev Dent; 1985; 7(3):11-7. PubMed ID: 3905180
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine and cardiovascular responses during phobic anxiety.
    Nesse RM; Curtis GC; Thyer BA; McCann DS; Huber-Smith MJ; Knopf RF
    Psychosom Med; 1985; 47(4):320-32. PubMed ID: 3895277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids do not reduce subjective fear in healthy subjects exposed to social stress.
    Soravia LM; de Quervain DJ; Heinrichs M
    Biol Psychol; 2009 Jul; 81(3):184-8. PubMed ID: 19482235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior therapy and the anxiety disorders: some conceptual and methodological issues.
    Carney RM
    Psychiatr Dev; 1985; 3(1):65-81. PubMed ID: 3889899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenelzine and exposure in the treatment of phobias.
    Solyom C; Solyom L; LaPierre Y; Pecknold J; Morton L
    Biol Psychiatry; 1981 Mar; 16(3):239-47. PubMed ID: 6112024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients.
    Kiive E; Maaroos J; Shlik J; Tõru I; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1007-13. PubMed ID: 15380861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.